Project Immune Overview
- Status
-
Private
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
1
Project Immune General Information
Description
Developer of a vaccine designed to prevent human damage from toxins. The company is currently operating in stealth mode.
Contact Information
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Corporate Office
- MS
- United States
Primary Industry
Drug Discovery
Corporate Office
- MS
- United States
Project Immune Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Accelerator/Incubator | Completed | Stealth |
Project Immune Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Mississippi State University Entrepreneurship Center | Accelerator/Incubator |
Project Immune FAQs
-
Where is Project Immune headquartered?
Project Immune is headquartered in MS.
-
What industry is Project Immune in?
Project Immune’s primary industry is Drug Discovery.
-
Is Project Immune a private or public company?
Project Immune is a Private company.
-
What is Project Immune’s current revenue?
The current revenue for Project Immune is .
-
Who are Project Immune’s investors?
Mississippi State University Entrepreneurship Center has invested in Project Immune.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
